CK Life Sciences Int'l., (Holdings) Inc. (HKG:0775)

HKG:0775 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 26, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	6,343	7,881	3,941	5,959	7,593	7,112
Market Cap Growth	33.33%	100.00%	-33.87%	-21.52%	6.76%	-15.91%
Enterprise Value	12,428	13,580	9,325	11,391	12,901	12,597
Last Close Price	0.66	0.82	0.41	0.62	0.78	0.72
PE Ratio	-	-	-	345.44	57.54	43.69
Forward PE	-	13.75	13.75	13.75	13.75	13.75
PS Ratio	1.17	1.46	0.71	1.12	1.44	1.32
PB Ratio	1.65	2.05	1.12	1.42	1.83	1.58
P/TBV Ratio	14.22	17.67	8.01	5.76	7.79	5.66
P/FCF Ratio	-	-	25.10	26.31	51.43	34.30
P/OCF Ratio	-	-	11.15	11.59	20.88	16.79
EV/Sales Ratio	2.30	2.51	1.69	2.14	2.45	2.33
EV/EBITDA Ratio	-	383.13	38.23	29.92	32.76	31.47
EV/EBIT Ratio	-	-	120.37	50.89	53.77	53.24
EV/FCF Ratio	-	-	59.39	50.29	87.38	60.75
Debt / Equity Ratio	1.72	1.72	1.74	1.42	1.43	1.38
Debt / EBITDA Ratio	186.80	186.80	18.91	12.96	12.63	12.85
Debt / FCF Ratio	-	-	38.85	26.19	40.27	29.96
Net Debt / Equity Ratio	1.57	1.57	1.57	1.25	1.26	1.18
Net Debt / EBITDA Ratio	169.79	169.79	22.66	13.80	13.31	13.27
Net Debt / FCF Ratio	-	-	35.21	23.20	35.51	25.61
Asset Turnover	0.48	0.48	0.50	0.47	0.46	0.46
Inventory Turnover	3.21	3.21	3.24	2.96	2.88	2.88
Quick Ratio	0.51	0.51	0.72	0.78	0.42	0.87
Current Ratio	0.87	0.87	1.28	1.43	0.77	1.53
Return on Equity (ROE)	-5.12%	-5.12%	-3.29%	0.41%	3.05%	3.53%
Return on Assets (ROA)	-0.72%	-0.72%	0.44%	1.24%	1.30%	1.25%
Return on Invested Capital (ROIC)	-1.33%	-1.39%	0.84%	0.60%	1.61%	1.64%
Return on Capital Employed (ROCE)	-1.60%	-1.60%	0.90%	2.40%	3.30%	2.50%
Earnings Yield	-2.94%	-2.37%	-3.21%	0.29%	1.74%	2.29%
FCF Yield	-	-	3.98%	3.80%	1.94%	2.92%
Dividend Yield	-	-	-	-	1.02%	1.39%
Payout Ratio	-	-	-	445.73%	72.83%	59.04%
Total Shareholder Return	-	-	-	-	1.02%	1.39%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.